Overview: Objective Parkinson’s Assessment with Kinesia HomeView™

Kinesia HomeView™ provides physicians with the resources to capture objective Parkinson’s disease symptoms from patients’ homes. Capturing symptoms at home where they matter most to a patient helps physicians prescribe more effective treatments and helps researchers understand new treatment responses. With the HomeView system, physicians have the tools to quantify tremor, assess dyskinesia and measure bradykinesia. A small take home kit, programmed to a specific patient’s symptoms and treatments, is sent home with the patient to complete different motor tests several times a day. The patient can also enter touch screen diary information about how they are feeling and when medications were taken. Physicians can view web-based reports including automated severity scoring and videos that show symptom changes during the day in response to treatments such as medication or deep brain stimulation.

FDA cleared to market
Parkinson's telemedicine

Kinesia technology is an FDA cleared to market and CE marked system to quantify motor assessments in the clinic and at home


CE certification ISO 13485 TGA certification Health Canada certification
Telemedicine to Quantify Motor Symptoms